Title:
MEDICINE CONTAINING FULLY SYNTHETIC ALPHA-PEPTIDE PROMOTING EXHAUSTION OF SODIUM FROM HUMAN PERICARDIUM
Document Type and Number:
Japanese Patent JPS61130236
Kind Code:
A
Abstract:
Fully synthetic alpha-human atrial natriuretic peptide (alpha-hANaP) in a highly purified injectable or infusible form is useful for treating cardiac insufficiency, more specifically with oedematosis and sodium retention, oliguric renal failure, blood pressure disregulation and ascites in chronic liver diseases, vasopressin disregulation, posterior pituitary malfunction, and the psychotropic effects induced thereby.
Inventors:
HESCH ROLF-DIETER (DE)
Application Number:
JP20250385A
Publication Date:
June 18, 1986
Filing Date:
September 11, 1985
Export Citation:
Assignee:
BISSENDORF PEPTIDE GMBH (DE)
International Classes:
A61K38/00; A61K38/22; A61K35/34; A61P5/00; A61P9/00; C07K14/58; (IPC1-7): A61K35/34; A61K37/02
Attorney, Agent or Firm:
Yasuo Yanagawa
Previous Patent: JPS61130235
Next Patent: COMPOSITION HAVING FAT AND OIL CONTAINING GAMMA-LINOLENIC ACID
Next Patent: COMPOSITION HAVING FAT AND OIL CONTAINING GAMMA-LINOLENIC ACID